Treating anxiety, depression and other disorders may depend on the amygdala, a part of the brain that controls strong emotional reactions, especially fear. But a deep understanding of this structure ...

GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.

One of the characteristics of depression is a tendency to perceive sensory stimuli and everyday situations in an excessively negative way. But the mechanisms underpinning this 'negativity bias,' which ...

New research shows that the threat response in the brain's amygdala (which processes emotions) is linked to different patterns of drinking by sex. In young males, heightened amygdala reactivity was ...

A new study suggests GLP-1 weight-loss drugs may be able to do more than curb appetite. Here's what researchers found.

GLP‑1 drugs appear to change how much we want to eat, and how strongly food “pulls” on the brain. Newer oral versions may ...